Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #01, April 2016
In a recent complaint, a Washington D.C. resident says her use of Johnson & Johnson’s Baby Powder and Shower to Shower has caused her to develop ovarian cancer and that the company ignored various studies evincing the products’ carcinogenic risks.
N.J. Federal Court Allows Parties in Talcum Powder Suit Another Month to Serve Affirmative Expert Reports
A New Jersey federal court overseeing a talc-based powder personal injury suit has amended its pretrial scheduling order, allowing the parties until May 27 to serve any affirmative expert reports.
Jury Selected in Second Missouri Talcum Powder Case; Court Denies Defense Motions for Summary Judgment, to Exclude Experts
The judge overseeing the second talcum powder case to proceed to trial in Missouri has issued orders denying defense motions for summary judgment, to exclude testimony and to transfer venue, according to the court’s online docket.
Plaintiffs have filed 14 new talc-based powder cases in New Jersey in the last three weeks, bringing the total number of cases pending in that state’s coordinated docket to 139, according to a recent published case list.
An October trial setting has been scheduled for the first talc-based powder case to proceed to trial in New Jersey’s coordinated docket, at which time a jury will hear claims from a woman who contends that her use of Johnson & Johnson’s Baby Powder caused her to develop ovarian cancer at the age of 36.
Parties involved in the second talc-based powder case to proceed to trial in St. Louis have started jury selection, sources with the court confirmed to HarrisMartin Publishing.
A Missouri judge overseeing a talcum powder case filed by 82 plaintiffs recently heard motions to dismiss in which the defendants argued, in part, that the court should sever the claims asserted by the majority of the plaintiffs on ground that they violate the forum non conveniens doctrine.
Imerys Talc America Inc. has challenged talcum powder claims pending in Missouri state court, contending that the court cannot exercise jurisdiction over Imerys simply because it has a registered agent in a nearby county and, further, that it did not mine or sell talc in Missouri.
A Missouri federal court has granted a talc-based powder plaintiff’s motion to dismiss the claims without prejudice despite defense objections, opining that the plaintiff had articulated a proper explanation for his desire to dismiss the action and that dismissal would not result in a waste of judicial time and effort.
A Washington, D.C., trial court has scheduled an April 2017 trial in a talc-based powder ovarian cancer lawsuit that joins a growing list of cases set to be tried over the next 12 months.